Počet záznamov: 1
Chloroquine inhibits stimulated platelets at the arachidonic acid pathway
Názov Chloroquine inhibits stimulated platelets at the arachidonic acid pathway Autor Nosáľ Radomír 1941-2020 SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV SCOPUS Spoluautori Jančinová Viera 1956- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV SCOPUS Petríková Margita 1958- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV SCOPUS Zdroj.dok. Thrombosis Research. Vol. 77, no. 6 (1995), p. 531-542 Jazyk dok. eng - angličtina Krajina US - Spojené štáty Druh dok. rozpis článkov z periodík (rbx) Ohlasy PROKOPENKO, R.A. - MOGILEVICH, S.E. - LUIK, A.I. - NAYDYENOVA, I.Y. - BATRAK, G.N. - HAWRYLUK, B.R. - DEGTIAR, V.Y. Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current. In GENERAL PHYSIOLOGY AND BIOPHYSICS. ISSN 0231-5882, 1995, vol. 14, no. 4, p. 349-357. MISRA, U.K. - GAWDI, G. - PIZZO, S.V. Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5-trisphosphate binding to its receptor. In JOURNAL OF CELLULAR BIOCHEMISTRY. ISSN 0730-2312, 1997, vol. 64, no. 2, p. 225-232. OGUOGHO, A. - ALMALICKY, B. - KRITZ, H. - SINZINGER, H. Chloroquine minimizes sampling artefacts for radioimmunological determination of thromboxane B-2 in plasma. In PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. ISSN 0952-3278, 1997, vol. 56, no. 5, p. 385-388. MARSALEK, M. - FILIP, V. - PETROVSKY, M. - KLAR, I. - FILIPOVA, M. - KLASCHKA, J. 7-MEOTA in the treatment of tardive dyskinesia. Double-blind placebo controlled study. In HOMEOSTASIS IN HEALTH AND DISEASE. ISSN 0960-7560, 1997, vol. 38, no. 1, p. 7-9 EDWARDS, M.H. - PIERANGELI, S. - LIU, X. - BARKER, J.H. - ANDERSON, G. - NIGEL HARRIS, E. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. In CIRCULATION. ISSN 0009-7322, 1997, vol. 96, no.12, p. 4380-4384 GOLDRING, J.P.D. - NEMAORANI, S. Antimalarial drugs modulate the expression of monocyte receptors. In INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. ISSN 0192-0561, 1999, vol. 21, no. 9, p. 599-607 WOLF, R. - WOLF, D. - RUOCCO, V. Antimalarials: Unapproved uses or indications. In CLINICS IN DERMATOLOGY. ISSN 0738-081X, 2000, vol. 18, no. 1, p. 17-35 NZERUE, C.M. - HEWAN-LOWE, K. - PIERANGELI, S. - HARRIS, E.N. "Black swan in the kidney": Renal involvement in the antiphospholipid antibody syndrome. In KIDNEY INTERNATIONAL. ISSN 0085-2538, 2002, vol. 62, no. 3, p. 733-744 YOON, K.H. Sufficient evidence to consider hydroxychloroquine as an adjunct therapy in antiphospholipid antibody (Hughes') syndrome [2]. In JOURNAL OF RHEUMATOLOGY. ISSN 0315-162X, 2002, vol. 29, no. 7, p. 1574-1575 JIMENEZ PALOP, M. Antimalarials: An update in rheumatic diseases | [Antipalúdicos: Actualización de su uso en enfermedades reumáticas]. In REUMATOLOGIA CLINICA. ISSN 1699-258X, 2006, vol. 2, no. 4, p. 190-201 RODRIGUES, J. - CHARRIS, J. - DOMINGUEZ, J. - ANGEL, J. - GAMBOA, N. Modification of oxidative status in Plasmodium berghei-infected erythrocytes by E-2-chloro-8-methyl-3-[(4 '-methoxy-1 '-indanoyl)-2 '-methyliden]-quinoline compared to chloroquine. In MEMORIAS DO INSTITUTO OSWALDO CRUZ. ISSN 0074-0276, 2009, vol. 104, no. 6, p. 865-870. BEN-ZVI, I. - KIVITY, S. - LANGEVITZ, P. - SHOENFELD, Y. Hydroxychloroquine: From Malaria to Autoimmunity. In CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY. ISSN 1080-0549, 2012, vol. 42, no. 2, p. 145-153. RODRIGUEZ-CARUNCHO, C. - BIELSA MARSOL, I. Antipalúdicos en dermatología: mecanismo de acción, indicaciones y efectos secundarios | [Antimalarials in dermatology: Mechanism of action, Indications, and side effects]. In ACTAS DERMO-SIFILIOGRAFICAS. ISSN 0001-7310, 2014, vol. 105, no. 3, p. 243-252 BELIZNA, C.Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome. In AUTOIMMUNITY REVIEWS. ISSN 1568-9972, 2015, vol. 14, no. 4, p. 358-362 GAMBOA DE DOMINGUEZ, N.D. - CHARRIS, J. - DOMINGUEZ, J. - MONASTERIOS, M. - ANGEL, J. - RODRIGUES, J. Effects of 5,8-dimethylthieno[2,3-b]quinoline-2-carboxylic acid on the antioxidative defense and lipid membranes in Plasmodium berghei-infected erythrocytes. In EXPERIMENTAL PARASITOLOGY. ISSN 0014-4894, 2015, vol. 155, p. 26-34. UPPAL, K. - SALINAS, J.L. - MONTEIRO, W.M. - VAL, F. - CORDY, R.J. - LIU, K. - MELO, G.C. - SIQUEIRA, A.M. - MAGALHAES, B. - GALINSKI, M.R. - LACERDA, M.V.G. - JONES, D.P. Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malaria. In PLOS ONE. ISSN 1932-6203, 2017, vol. 12, no. 8, article number e0182819. LITVIK, R. Use of antimalarials in dermatology. In CESKO-SLOVENSKA DERMATOLOGIE. ISSN 0009-0514, 2017, vol. 92, no. 2, p. 55-61. FELSENSTEIN, S. - HERBERT, J.A. - MCNAMARA, P.S. - HEDRICH, C.M. COVID-19: Immunology and treatment options. In CLINICAL IMMUNOLOGY. ISSN 1521-6616, 2020, vol. 215, art. no. UNSP 108448. SCHREZENMEIER, E. - DORNER, T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. In NATURE REVIEWS RHEUMATOLOGY. ISSN 1759-4790, 2020, vol. 16, no. 3, p. 155-166. VITTE, J. - MICHEL, M. - MEZOUAR, S. - DIALLO, A.B. - BOUMAZA, A. - MEGE, J.L. - DESNUES, B. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines. In FRONTIERS IN IMMUNOLOGY. ISSN 1664-3224, 2020, vol. 11. PAL, A. - PAWAR, A. - GOSWAMI, K. - SHARMA, P. - PRASAD, R. Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update. In INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY. ISSN 0970-1915, 2020, vol. 35, no. 3, p. 274-284. DEVAUX, C.A. - CAMOIN-JAU, L. - MEGE, J.L. - RAOULT, D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?. In JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION. ISSN 1684-1182, 2021, vol. 54, no. 1, p. 37-45. ESLAMKHAH, S. - ALIZADEH, N. - HAJIASGHARZADEH, K. - ESLAMKHAH, M. - MOKHTARZADEH, A. - BARADARAN, B. The Clinical Characteristics and Treatment Approaches of COVID-19: A Concise Review. In PHARMACEUTICAL SCIENCES. ISSN 1735-403X, NOV 2021, vol. 27, p. S50-S67. GRYGIEL-GORNIAK, B. Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic. In CLINICAL RHEUMATOLOGY. ISSN 0770-3198, JAN 2022, vol. 41, no. 1, p. 1-18. NIEMANN, B. - PULEO, A. - STOUT, C. - MARKEL, J. - BOONE, B.A. Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer. In PHARMACEUTICS. DEC 2022, vol. 14, no. 12. Dostupné na: https://doi.org/10.3390/pharmaceutics14122551. PIETTO, M.C.B. - GLEMBOTSKY, A.C. - LEV, P.R. - OYARZúN, C.R.M. - DE LUCA, G. - GOMEZ, G. - COLLADO, M.V. - CHARó, N. - CELLUCCI, A.S. - HELLER, P.G. - GOETTE, N.P. - MARTA, R.F. Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus. In IMMUNOBIOLOGY. ISSN 0171-2985, JAN 2024, vol. 229, no. 1. Dostupné na: https://doi.org/10.1016/j.imbio.2023.152782. KIM, Y.M. - SUNG, J.H. - CHA, H.H. - OH, S.Y. Hydroxychloroquine in obstetrics: potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy. In OBSTETRICS & GYNECOLOGY SCIENCE. ISSN 2287-8572, MAR 2024, vol. 67, no. 2, p. 143-152. Dostupné na: https://doi.org/10.5468/ogs.23252. HIRAOKA, D. - ISHIZAKI, J. - YAMANOUCHI, J. - HONDA, T. - NIIYA, T. - HORIMOTO, E. - HORIE, K. - YAMASAKI, H. - MATSUMOTO, T. - SUEMORI, K. - HASEGAWA, H. - TAKENAKA, K. Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS). In LUPUS SCIENCE & MEDICINE. ISSN 2053-8790, JUL 2024, vol. 11, no. 2. Dostupné na: https://doi.org/10.1136/lupus-2024-001223. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 1995 Registrované v WOS Registrované v SCOPUS DOI 10.1016/0049-3848(95)00028-3 
článok
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 1995
Počet záznamov: 1